Who Owns Insmed Stock?
NASDAQ: INSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 99.00 -1.59%
Ownership breakdown
- Held by institutions
- 105.06%
- Institutions (% of float)
- 105.60%
- Held by insiders
- 0.51%
- Institutional holders
- 975
- Institutions 99.5%
- Insiders 0.5%
- Public and other 0.0%
Who owns Insmed stock?
Institutional investors own about 105.1% of Insmed's shares, spread across 975 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.51% of INSM.
The largest institutional holders are FMR, LLC (7.39%), Blackrock Inc. (7.24%) and JPMORGAN CHASE & CO (4.78%). Together, the top 10 institutions control 45.0% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their INSM positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of INSM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 16.14M | 7.39% | +22.7% |
| Blackrock Inc. | 15.81M | 7.24% | -5.2% |
| JPMORGAN CHASE & CO | 10.43M | 4.78% | -56.8% |
| Vanguard Portfolio Management LLC | 10.41M | 4.77% | +0.3% |
| Vanguard Capital Management LLC | 9.79M | 4.48% | +1.5% |
| Baker Bros. Advisors, LP | 8.80M | 4.03% | +18.5% |
| Capital International Investors | 8.24M | 3.77% | +47.2% |
| Darwin Global Management, Ltd. | 6.43M | 2.94% | -61.7% |
| Ameriprise Financial, Inc. | 6.18M | 2.83% | +102.1% |
| Orbis Allan Gray Ltd | 6.08M | 2.78% | +224.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of INSM
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 6.88M | 3.15% |
| Growth Fund of America | 6.25M | 2.86% |
| JPMorgan Trust II-JPMorgan Large Cap Growth Fund | 2.79M | 1.28% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.49M | 1.14% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.49M | 1.14% |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.35M | 1.08% |
| VANGUARD INDEX FUNDS-Vanguard Growth Index Fund | 1.80M | 0.83% |
| Fidelity Advisor Series I-Fidelity Advisor Growth Opportunities Fund | 1.65M | 0.76% |
| iShares Trust-iShares Biotechnology ETF | 1.61M | 0.74% |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | 1.43M | 0.66% |
Frequently asked questions
Who is the largest shareholder of Insmed?
FMR, LLC is the largest institutional shareholder of INSM, owning 7.39% of shares outstanding (16.14M shares) as of its latest 13F filing.
What percentage of Insmed is owned by institutions?
Institutions own about 105.1% of INSM shares and 105.6% of the public float.
How much of Insmed do insiders own?
Insiders, such as officers and directors, own about 0.51% of INSM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.